Cardiac repair - Fact or fancy?

Heart Failure Reviews

Volumn 11, Issue 2, 2006, Pages 155-170

  Leontiadis, E ^a   Manginas, A ^a   Cokkinos, D V ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bone marrow derived cells; Cardiac regeneration; Cardiac repair; Heart failure; Myoblasts; Myocardial infarction; Stem cells

Indexed keywords

8 QUINOLINOL INDIUM IN 111; ANGIOGENIC FACTOR; CHEMOKINE RECEPTOR CXCR4; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; GRANULOCYTE COLONY STIMULATING FACTOR; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MONOCYTE CHEMOTACTIC PROTEIN 1; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ACUTE HEART INFARCTION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR SURGERY; CELL SECRETION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEFIBRILLATION; FLUORESCENCE ANALYSIS; FLUOROSCOPY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HEART SCINTISCANNING; HEART TRANSPLANTATION; HISTOGENESIS; HUMAN; IMAGING SYSTEM; ISCHEMIC HEART DISEASE; MICROSCOPY; MYOCARDIAL HIBERNATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN DONOR; OUTCOME ASSESSMENT; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL MOBILIZATION; TISSUE REPAIR; TISSUE SPECIFICITY; TREATMENT OUTCOME;

CARDIOMYOPATHIES; CYTOKINES; HUMANS; MYOCARDIAL ISCHEMIA; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION;

EID: 33747881388     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-006-9486-8     Document Type: Article

References (130)

1. Park SJ, Tector A, Picconi W, et al. Left ventricular assist devices as destination therapy: A new look at survival. J Thorac Cardiovasc. Surg 2005;129:9-17.
2. Boehmer JR. Device therapy for heart failure. Am J Cardiol 2003;91:53D-9D.
3. McAlister FA, Ezekowitz JA, Wiebe N, et al. Systematic review: Cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004;141:381-90.
4. Batista RJ, Santos JL, Takeshita N, et al. Partial ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 1996;11:96-7.
5. Robbins RC, Barlow CW, Oyer PE, et al. Thirty years of cardiac transplantation at Stanford University. J Thorac Cardiovasc Surg 1999;117:939-51.
6. Greenberg H, Case RB, Moss AJ, et al. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-65.
7. Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004;364:183-92.
8. Strauer BE, Kornowski R. Stem cells in perspective. Circulation 2003;107:929-34.
9. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001;279-80.
10. Koh GY, Klug MG, Soonpaa MH, et al. Differentiation and long -Term survival of c2c12 myoblast grafts in heart. J Clin Invest 1993;92:1548-54.
11. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nature Med 1998;4:929-33.
12. Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996;98:2512-23.
13. Reinecke H, Popa V, Murry CE, et al. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241-9.
14. Abraham MR, Henrikson CA, Tung L, et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 2005;97:159-67.
15. Wagers AJ, Weissmann IL. Plasticity of adult stem cells. Cell 2004;116:639-48.
16. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7.
17. Kajstura J, Leri A, Finato L, et al. Myocyte proliferation in end - stage cardiac failure in humans. Proc Natl Acad Sci USA 1998;95:8801-05.
18. Quaini F, Urbanek K, Kajstura J, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15.
19. Laflamme MA, Myerson D, Saffitz JE, et al. Evidence of cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002;90:634-40.
20. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
21. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100:12313-8.
22. Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433:647-53.
23. Pfister O, Mouquet F, Jain M, et al. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005;97:52-61.
24. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-21.
25. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infracted heart, improving function and survival Proc Natl Acad Sci USA 2001;98:10344-9.
26. Jackson KA, Maijka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-2.
27. Deb A, Wang S, Skelding KA, et al. Bone marrow - derived cardiomyocytes are present in adult human heart: A study 0f gender - mismatched bone marrow transplantation patients. Circulation 2003;107:1247-9.
28. Laugwitz KL, Moretti A, Lam J, et al. Postnatal isI1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433:585-7.
29. Wessels A, Perez-Pomares JM. The epicardium and epicardially derived cells (EPDcs) as cardiac stem cells. Anat Rec 2004;276:43-57.
30. Orlic D, Hill J, Arai A. Stem cells for myocardial regeneration. Circ Res 2002;91:1092-1102.
31. Koerbling M, Zeev E. Adult stem cells for tissue repair - A new therapeutic concept? N Engl J Med 2003;349:570-82.
32. Dimmmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 2005;115:572-83.
33. Forrester JS, Price MJ, Makkar RR. Stem Cell Repair of infacted myocardium. An overview for clinicians. Circulation 2003;108:1139-45.
34. Ying Q-L, Nichols J, Evans E, et al. Changing potency by spontaneous fusion. Nature 2002;416:545-8.
35. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
36. Toma C, Pittenger MF, Cahil KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98.
37. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100:II247-56.
38. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001;37:1726-32.
39. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-88.
40. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83.
41. Siminiak T, Kalawski R, Fiszer D, et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am Heart J 2004;148:531-7.
42. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003;24:2012-20.
43. Chachques JC, Herreros J, Trainini, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004;95(suppl I):29-33.
44. Mocini D, Staibano M, Mele L, et al. Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery by pass grafting. Am Heart J 2006;151:192-7.
45. Smits PC, van Gens RJ, Poldermans D, et al. Catheter - based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J Am Coll Cardiol 2003;42:1070-2.
46. Siminiak T, Fiszer D, Jerzykowska O, et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart 2005;26:1188-95.
47. Dib N, Michler R, Pagani F, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Four-year follow-up. Circulation 2005;112:1748-55.
48. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6.
49. Stamm C, Kleine HD, Westphal B, et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 2004;52:152-8.
50. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease. J Am Coll Cardiol 2005;46:1651-58.
51. Erbs S, Linke A, Adams V, et al. Transplantation of blood - derived progenitor cells after recanalization of chronic coronary artery occlusion, Circ Res 2005;97:576-62.
52. Hamano K, Nishida M, Hirata K, et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: Clinical trial and preliminary results. Jpn Circ J 2001;65:845-7.
53. Tse HF, Kwong YL, Chan JK, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-9.
54. Fuchs S, Satler LF, Kornowski R, et al. Catheter - based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: A feasibility study. J Am Coll Cardiol 2003;41:1721-4.
55. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-2302.
56. Dohmann HFR, Perin EC, Yakiya CM, et al. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure. Postmortem anatomicopathologic and immunohistochemical findings. Circulation 2005;112:521-6.
57. Gowdak LHW, Schettert IT, Rienzo M, et al. Long-term safety of intramyocardial injection of autologous bone marrow cells for severe ischemic heart disease (Abstract). J Am Coll Cardiol 2006;47:(Suppl A) 165.
58. Blatt A, Cotter G, Leitman M, et al. Intracoronary administation of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy. Am Heart J 2005;150:986.e1-7.
59. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8.
60. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction Circ Res 2004;95:742-8.
61. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI) Circulation 2002;106:3009-17.
62. Schaechinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004;44:1690-9.
63. Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-5.
64. Vulliet PR, Greeley M, Halloran SM, et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004;363:784-84.
65. Katritsis DG, Sotiropoulou PA-Karvouni E, et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted myocardium. Catheter Cardiovasc Interv 2005;65:321-9.
66. Kuethe F, Richartz BM, Sayer HG, et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 2004;97:123-7.
67. Bartunek J, Vanderheyden M, Vandekerckhove M, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction. Circulation 2005;112:I178-83.
68. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomized controlled clinical trial. Lancet 2004;364:141-8.
69. Jannsens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double blind, randomized controlled trial. Lancet 2006;367:113-21.
70. Wright DE, Wagers AJ, Gulati AP, et al. Physiologic migration of hematopoietic stem and progenitor cells. Science 2001;294:1933-6.
71. Ceradini DJ, et al, Progenitor cell trafficking is regulated by hypoxic gradients through hif-1 induction of sdf-1 Nat Med 2004;10:858-64.
72. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109:625-37.
73. Deten A, Volz HC, Briest W, et al. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction: Experimental study in rats Cardiovasc Res 2002;55:329-40.
74. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularisation of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine 2001;7:430-6.
75. Minatoguchi S, Takemura G, Chen XH, et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor. Circulation 2004;109:2572-80.
76. Harada M, Qin Y, Takano H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005;11:305-11.
77. Sugano Y, Anzai T, Yoshikawa T, et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res. 2005;65:446-56.
78. Norol F, Merlet P, Isnard R, et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 2003;102:4361-8.
79. Terrovitis J, Charitos C, Dolou P, et al. No effect of stem cell mobilization with GM-CSF on infarct size and left ventricular function in experimental acute myocardial infarction. Basic Res Cardiol 2004;99:241-6.
80. Chachques JC, Duarte F, Cattadori B, et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: A comparative study. J Thorac Cardiovasc Surg 2004;128:245-53.
81. Sesti C, Hale SL, Lutzko C, et al. Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. J Am Coll Cardiol 2005;46:1662-9.
82. Zohlnhofer D, Otti I, Mehilli J, et al. REVIVAL-2 Investigators. Stem cell mobilization by granulocyte colony - stimulating factor in patients with acute myocardial infraction: A randomized controlled trial. JAMA 2006;295:1003-10.
83. Pompilio G, Cannata A, Peccatori F, et al. Autologous peripheral blood stem cell transplantation for myocardial regeneration: A novel strategy for cell collection and surgical injection. Ann Thorac Surg 2004;78:1812-3.
84. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
85. Ince H, Petzsch M, Kleine HD, et al. Preservation From Left Ventricular Remodeling by Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Use of Granulocyte-Colony-Stimulating Factor (FIRSTLINE-AMI) Circulation 2005;112:3097-3106.
86. Jorgensen E, Ripa RS, Helqvist S, et al. In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor. Preliminary intracoronary ultrasound results from a double - blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial). Int J Cardiol. 2005 (Epub ahead of print).
87. Hill JM, Syed MA, Arai AE, et al. Outcomes and Risks of Granulocyte Colony-Stimulating Factor in Patients with coronary artery disease. J Am Coll Cardiol 2005;46:1643-8.
88. Zbinden S, Zbinden R, Meier P, et al. Safety and efficacy on subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral crowth promotion in patients with coronary artery disease. JACC 2005;46:11636-42.
89. Wilson FR, Henry TD. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. JACC 2005;46:1649-50.
90. Boyle AJ, Whitbourn R, Schlicht S, et al. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up. Int J Cardiol 2005 (Epub ahead of print).
91. Huettmann A, Duehrsen U, Stypmann J, et al. Granulocyte colony-stimulating factor-induced blood stem cell mobilization in patients with chronic heart failure. Basic Res Cardiol 2006;101:78-86.
92. Wang Y, Taegil K, Ripa RS, et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 2005;100:477-83.
93. Kuethe F, Figulla HR, Herzau M, et al. Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction. Am Heart J 2005;150:115.e1-7.
94. Korn R, Schoor M, Neuhaus H, et al. Enhancer trap integrations in mouse embryonic stem cells give rise to staining patterns in chimaeric embryos with a high frequency and detect endogenous genes. Mech Dev 1992;39:95-109.
95. Mansour SL, Thomas KR, Dend CX, et al. Introduction of a lacZ reporter gene into the mouse int-2 locus by homologous recombination. Proc Natl Acad Sci USA 1990;87(19):7688-92.
96. Etzion S, Battler A, Barbasch IM,et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 2001;33:1321-30.
97. Chiu RC, Zibaitis A, Kao RL, et al. Cellular cardiomyoplasty: Myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995;60:12-8.
98. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovasculaization. Circ Res 1999;85:221-8.
99. Wang JS, Shum-Tim D, Chedrawy E, et al. The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 2001;122:699-705.
100. Suzuki K, Murtuza B, Fukushima S, et al. Targeted cell delivery into infarcted rat heart sby retrograde intracoronary infusion: Distribution, dynamics, and influence on cardiac function. Circulation 2004;110(11 Suppl 1) 225-30.
101. Patt HM, Maloney MA, Lamela RA. Hematopoietic stem cell proliferative behavior as revealed by bromodeoxyuridine labeling. Exp Hematol 1980;8:1075-9.
102. Reinecke H, Zhang M, Bartosek T, et al. Survival, integration and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation 1999;100:193-202.
103. Skobel E, Schuh A, Schwarz ER, et al. Transplanatation of fetal cardiomyocytes into infarcted hearts results in long-term functional improvement. Tissue Eng 2004;10:849-64.
104. Merx MW, Zernecke A, liehn EA, et al. Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Res Cardiol. 2005;100:208-16.
105. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
106. Kajstura J, Rota M, Whang B, et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005;96:6-8.
107. Roell W, Lu ZJ, Bloch W, et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 2002;105:2435-41.
108. Kawada H, Fujita J, Kinjo K, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004;104:3581-7.
109. Fukuda K, Fujita J. Mesenchymal, but not hematopoieic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. Kidney Int 2005;68:1940-3.
110. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107:2134-9.
111. Saeed M, Saloner D, Weber O, et al. MRI in guiding and assessing intramyocardial therapy. Eur Radiol 2005;15:851-63.
112. Britten MB, Abomaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): Mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003;108:2212-8.
113. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal cells in myocardial infarction. Circulation 2003;107:2290-3
114. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003;108:1009-14.
115. Garot J, Unterseeh T, Teiger E, et al. Magnetic resonance imaging of targeted catheter - based implantation of myogenic precursor cells into infarcted left ventricular myocardium. J Am Coll Cardiol 2003;41:1841-6.
116. Lederman RJ, Guttman MA, Peters DC, et al. Catheter-based endomyocardial injection with real-time magnetic resonance imaging. Circulation 2002;105:1282-4.
117. Dick AJ, Guttman MA, Raman VK, et al. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation 2003;108:2899-904.
118. Barbash IM, Leor J, Feiberg MS, et al. Interventional magnetic resonance imaging for guiding gene and cell transfer in the heart. Heart 2004;90:1-2.
119. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 2001;1:326-33.
120. Rennen HJ, Boerman OC, Oyen WJ, et al. Imaging infection/inflammation in the new millenium. Eur J Nucl Med 2001;28:241-52.
121. Gao J, Dennis JE, Muzic RF, et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001;169:12-20.
122. Brenner W, Aicher A, Eckey T, et al. 111 In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 2004;45:512-8.
123. Chin BB, Nakamoto Y, Bulte JW, et al. 111 In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun 2003;24:1149-5.
124. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003;108:863-8
125. Hofmann M, Wollert KC, Meyer GP, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111:2198-2202.
126. G. Karatasakis, A. Manginas, E. Leontiadis, et al. Longitudinal myocardial strain and strain rate changes six months after intracoronary autologous bone marrow stem cell infusion. American Heart Association scientific sessions, November 2004.
127. Manginas A, Leontiadis E, Goussetis E, et al. Perfusion and dilatation of old myocardial infarction improve after intracoronary autologous bone marrow stem cell transplantation. E Heart J 2004;25:349.
128. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from thge randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation, infarct regeneration) trial. Circulation 2006;113:1287-94.
129. Welt FG, Losordo DW. Cell therapy for acute myocardial infarction: Curb your enthusiasm? Circulation 2006;113:1272-4.
130. Bartunek J, Dimmeler S, Drexler H, et al. The consensus of the task force of the Eurpean Society of Cardiologu concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006 [Epub ahead of print].